These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1977888

  • 1. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
    Hall H, Wedel I, Halldin C, Kopp J, Farde L.
    J Neurochem; 1990 Dec; 55(6):2048-57. PubMed ID: 1977888
    [Abstract] [Full Text] [Related]

  • 2. Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.
    Inoue O, Kobayashi K, Tsukada H, Itoh T, Langstrom B.
    J Neural Transm Gen Sect; 1991 Dec; 85(1):1-10. PubMed ID: 1678266
    [Abstract] [Full Text] [Related]

  • 3. Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone.
    Inoue O, Kobayashi K, Hosoi R, Yamaguchi M, Gee A.
    J Neural Transm (Vienna); 1999 Dec; 106(11-12):1099-104. PubMed ID: 10651106
    [Abstract] [Full Text] [Related]

  • 4. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
    Young LT, Wong DF, Goldman S, Minkin E, Chen C, Matsumura K, Scheffel U, Wagner HN.
    Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
    Inoue O, Wakahara S, Kobayashi K, Gee A.
    J Neural Transm (Vienna); 1999 Nov; 106(2):131-7. PubMed ID: 10226933
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V, Ruottinen HM, Någren K, Lehikoinen P, Oikonen V, Rinne JO.
    J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
    [Abstract] [Full Text] [Related]

  • 7. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P.
    Synapse; 2004 Sep 15; 53(4):222-33. PubMed ID: 15266554
    [Abstract] [Full Text] [Related]

  • 8. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
    Kobayashi K, Inoue O, Watanabe Y, Onoe H, Långström B.
    J Neural Transm Gen Sect; 1995 Sep 15; 100(2):147-51. PubMed ID: 8962684
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 10. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 16; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 11. D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding.
    Lyon RA, Titeler M, Bigornia L, Schneider AS.
    J Neurochem; 1987 Feb 16; 48(2):631-5. PubMed ID: 3794725
    [Abstract] [Full Text] [Related]

  • 12. Changes in apparent in vivo binding of [3H]raclopride and [3H]N-methylspiperone induced by oxotremorine.
    Kobayashi K, Gee A, Hosoi R, Inoue O.
    J Neural Transm (Vienna); 1998 Feb 16; 105(10-12):1193-7. PubMed ID: 9928888
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

  • 14. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H, Wedel I.
    Acta Pharmacol Toxicol (Copenh); 1986 May 15; 58(5):368-73. PubMed ID: 2943136
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
    Dewar KM, Montreuil B, Grondin L, Reader TA.
    J Pharmacol Exp Ther; 1989 Aug 15; 250(2):696-706. PubMed ID: 2527300
    [Abstract] [Full Text] [Related]

  • 16. Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies.
    Bischoff S, Gunst F.
    J Recept Signal Transduct Res; 1997 Aug 15; 17(1-3):419-31. PubMed ID: 9029505
    [Abstract] [Full Text] [Related]

  • 17. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun 15; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 18. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
    Ostergaard SD, Alstrup AK, Gramsbergen JB, Minuzzi L, Pedersen K, Jensen SB, Doudet D, Cumming P.
    Synapse; 2010 Jan 15; 64(1):70-82. PubMed ID: 19768811
    [Abstract] [Full Text] [Related]

  • 19. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M, Hidaka K, Nakamura Y.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):177-82. PubMed ID: 2576228
    [Abstract] [Full Text] [Related]

  • 20. Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease.
    Ishibashi K, Ishii K, Oda K, Mizusawa H, Ishiwata K.
    Nucl Med Commun; 2010 Feb 07; 31(2):159-66. PubMed ID: 19966595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.